C4 THERAPEUTICS INC (CCCC) Forecast, Price Target & Analyst Ratings

NASDAQ:CCCC • US12529R1077

Current stock price

2.73 USD
+0.01 (+0.37%)
At close:
2.73 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for C4 THERAPEUTICS INC (CCCC).

Forecast Snapshot

Consensus Price Target

Price Target
$11.51
+ 321.66% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
-$0.27
Revenue Estimate
4.896M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.71%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$11.51
Upside
+ 321.66%
From current price of $2.73 to mean target of $11.51, Based on 14 analyst forecasts
Low
$5.05
Median
$7.14
High
$31.50

Price Target Revisions

1 Month
14.49%
3 Months
-4.82%

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for CCCC. The average price target is 11.51 USD. This implies a price increase of 321.66% is expected in the next year compared to the current price of 2.73.
The average price target has been revised downward by 4.82% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CCCC Current Analyst RatingCCCC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

CCCC Historical Analyst RatingsCCCC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
85.71%
CCCC was analyzed by 14 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CCCC.
In the previous month the buy percentage consensus was at a similar level.
CCCC was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-27BarclaysMaintains Overweight -> Overweight
2026-02-23Brookline CapitalMaintains Buy -> Buy
2025-12-17BarclaysMaintains Overweight -> Overweight
2025-12-02TD CowenInitiate Buy
2025-09-23BarclaysMaintains Overweight -> Overweight
2025-09-23Wells FargoMaintains Overweight -> Overweight
2025-09-22Stephens & Co.Reiterate Overweight -> Overweight
2025-09-17BarclaysInitiate Overweight
2025-09-15Stephens & Co.Upgrade Equal-Weight -> Overweight
2025-09-04GuggenheimInitiate Buy
2024-12-19Wells FargoUpgrade Equal-Weight -> Overweight
2024-11-18Stephens & Co.Initiate Equal-Weight
2024-08-06BMO CapitalReiterate Outperform -> Outperform
2024-05-09StifelMaintains Buy -> Buy
2024-05-09Wells FargoMaintains Equal-Weight -> Equal-Weight
2024-02-26Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2024-02-23StifelReiterate Buy -> Buy
2024-01-29JP MorganUpgrade Underweight -> Neutral
2023-12-13StifelUpgrade Hold -> Buy
2023-11-06Morgan StanleyUpgrade Underweight -> Equal-Weight
2023-11-03BMO CapitalMaintains Outperform -> Outperform
2023-11-02HC Wainwright & Co.Maintains Buy -> Buy
2023-10-09B of A SecuritiesMaintains Neutral -> Neutral
2023-08-09HC Wainwright & Co.Maintains Buy -> Buy
2023-05-30Evercore ISI GroupMaintains Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
-$0.27
Revenue Estimate
4.896M
Revenue Q2Q
-32.36%
EPS Q2Q
28.05%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
44.00%
Revenue (3 Months)
44.00%
EPS (1 Month)
14.00%
EPS (3 Months)
14.00%

Next Earnings Summary

CCCC is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is -0.27 USD and the consensus revenue estimate is 4.90M USD.
The next earnings revenue estimate has been revised upward by 44% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CCCC revenue by date.CCCC revenue by date.
20.756M
-33.26%		35.584M
71.44%		35.947M
1.02%		22.979M
-36.08%		22.979M29.665M
29.10%		636.05M
2,044.11%		2.03B
219.16%		333.32M
-83.58%		499.42M
49.83%		741.83M
48.54%
EBITDA
YoY % growth
CCCC ebitda by date.CCCC ebitda by date.
-137.151M
-7.27%		-115.359M
15.89%		-102.53M
11.12%		-124.44M
-21.37%		-137.7M
-10.66%		-117.3M
14.81%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
CCCC ebit by date.CCCC ebit by date.
-139.031M
-7.33%		-117.177M
15.72%		-104.489M
10.83%		-151.945M
-45.42%		-159.477M
-4.96%		-108.292M
32.10%		31.106M
128.72%		580.32M
1,765.62%		87.126M
-84.99%		252.48M
189.79%		398.34M
57.77%
Operating Margin
CCCC operating margin by date.CCCC operating margin by date.
-669.84%-329.30%-290.68%-661.24%-694.01%-365.05%4.89%28.59%26.14%50.55%53.70%
EPS
YoY % growth
CCCC eps by date.CCCC eps by date.
-2.66
-1.14%		-1.51
43.23%		-1.36
9.93%		-1.25
7.84%		-1.06
15.36%		-0.98
7.97%		-0.93
4.93%		-0.21
77.29%		1.14
639.43%		2.28
100.45%		3.12
36.69%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.27
28.05%		-0.29
21.85%		-0.35
21.12%		-0.39
-118.59%
Revenue
Q2Q % growth		4.896M
-32.36%		4.386M
-32.14%		3.4M
-69.72%		3.4M
-69.14%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-34.643M
-18.79%		-38.042M
-33.47%		-43.86M
-85.23%		-46.92M
-102.72%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CCCC Yearly Revenue VS EstimatesCCCC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B
CCCC Yearly EPS VS EstimatesCCCC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5 -10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
8.64%
EPS Next 5 Year
13.03%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-2.27%
Revenue Next 5 Year
129.64%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
2.43%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

C4 THERAPEUTICS INC / CCCC Forecast FAQ

What is the price target for CCCC stock?

14 analysts have analysed CCCC and the average price target is 11.51 USD. This implies a price increase of 321.66% is expected in the next year compared to the current price of 2.73.

When does C4 THERAPEUTICS INC (CCCC) report earnings?

C4 THERAPEUTICS INC (CCCC) will report earnings on 2026-05-05.

Can you provide the consensus estimates for C4 THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of C4 THERAPEUTICS INC (CCCC) is -0.27 USD and the consensus revenue estimate is 4.90M USD.

What is the expected long term growth rate for CCCC stock?

The expected long term growth rate for C4 THERAPEUTICS INC (CCCC) is -2.27%.